MAOA and Alzheimer disease: Another possible explanation for disruptions in melatonin production in AD might be deficiencies in melatonin’s precursor serotonin (5-HT) or decreases in norepinephrine, which is responsible for activating the pineal gland via β-receptors, due to increased MAO-A activity in AD.